Related Experiment Video
Updated: May 4, 2026
06:21
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
2.2K
GM3 and diabetes.
1Division of Glycopathology, Institute of Molecular Biomembranes and Glycobiology, Tohoku Pharmaceutical University, 4-4-1, komatsushima, Aoba-ku, Sendai, 981-8558, Miyagi, Japan, jin@tohoku-pharm.ac.jp.
Glycoconjugate Journal
|January 9, 2014
Summary
Type 2 diabetes and insulin resistance stem from impaired insulin receptor and GM3 ganglioside interactions in fat cells. Aberrant ganglioside expression may cause metabolic disorders, suggesting new diagnostic and therapeutic approaches.
Area of Science:
- Biochemistry
- Molecular Biology
- Metabolic Disorders
Background:
- Insulin resistance and type 2 diabetes are significant global health challenges.
- The molecular mechanisms underlying these metabolic disorders are not fully understood.
- Membrane microdomains play crucial roles in cellular signaling and function.
Purpose of the Study:
- To elucidate the molecular pathogenesis of type 2 diabetes and insulin resistance.
- To investigate the role of insulin receptor and GM3 ganglioside interactions in adipocytes.
- To propose a novel hypothesis linking metabolic disorders to ganglioside expression and membrane microdomains.
Main Methods:
- Focus on the interaction between the insulin receptor and GM3 ganglioside in adipocytes.
- Utilized molecular and cellular biology techniques to study these interactions.
- Proposed a working hypothesis based on experimental observations.
Main Results:
- Demonstrated a specific interaction between the insulin receptor and GM3 ganglioside in adipocytes.
- Identified aberrant expression of gangliosides as a potential cause of metabolic disorders.
- Established a link between membrane microdomains and the pathogenesis of type 2 diabetes.
Conclusions:
- Metabolic disorders, including type 2 diabetes, may arise from membrane microdomain dysfunction due to aberrant ganglioside expression.
- This finding supports a new hypothesis: "metabolic disorders are membrane microdomain disorders caused by aberrant expression of gangliosides".
- Suggests potential for novel diagnostic methods identifying specific ganglioside species for metabolic syndrome and a therapeutic strategy termed "membrane microdomain ortho-signaling therapy".
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
01:29Hyperglycemia
25
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25
01:19Type I Diabetes III: Clinical Manifestations
26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17
01:26Diabetes Mellitus: Introduction
24
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
24
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K